Logo image of SUZ

SUZANO SA - SPON ADR (SUZ) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:SUZ - US86959K1051 - ADR

8.95 USD
-0.01 (-0.11%)
Last: 11/28/2025, 8:02:12 PM
8.95 USD
0 (0%)
After Hours: 11/28/2025, 8:02:12 PM
Fundamental Rating

7

SUZ gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 9 industry peers in the Paper & Forest Products industry. While SUZ has a great profitability rating, there are some minor concerns on its financial health. SUZ may be a bit undervalued, certainly considering the very reasonable score on growth SUZ also has an excellent dividend rating. With these ratings, SUZ could be worth investigating further for value and dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SUZ was profitable.
In the past year SUZ had a positive cash flow from operations.
In multiple years SUZ reported negative net income over the last 5 years.
SUZ had a positive operating cash flow in each of the past 5 years.
SUZ Yearly Net Income VS EBIT VS OCF VS FCFSUZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

The Return On Assets of SUZ (4.91%) is better than 66.67% of its industry peers.
SUZ's Return On Equity of 18.14% is fine compared to the rest of the industry. SUZ outperforms 77.78% of its industry peers.
SUZ has a better Return On Invested Capital (7.05%) than 77.78% of its industry peers.
SUZ had an Average Return On Invested Capital over the past 3 years of 9.38%. This is above the industry average of 5.80%.
Industry RankSector Rank
ROA 4.91%
ROE 18.14%
ROIC 7.05%
ROA(3y)7.7%
ROA(5y)3.96%
ROE(3y)26.78%
ROE(5y)-2.15%
ROIC(3y)9.38%
ROIC(5y)9.39%
SUZ Yearly ROA, ROE, ROICSUZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

The Profit Margin of SUZ (15.26%) is better than 100.00% of its industry peers.
The Operating Margin of SUZ (25.74%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of SUZ has grown nicely.
With an excellent Gross Margin value of 37.73%, SUZ belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of SUZ has grown nicely.
Industry RankSector Rank
OM 25.74%
PM (TTM) 15.26%
GM 37.73%
OM growth 3Y-8.96%
OM growth 5Y26.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.3%
GM growth 5Y15.81%
SUZ Yearly Profit, Operating, Gross MarginsSUZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SUZ is still creating some value.
The number of shares outstanding for SUZ has been reduced compared to 1 year ago.
The number of shares outstanding for SUZ has been reduced compared to 5 years ago.
SUZ has a worse debt/assets ratio than last year.
SUZ Yearly Shares OutstandingSUZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SUZ Yearly Total Debt VS Total AssetsSUZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

SUZ has an Altman-Z score of 1.22. This is a bad value and indicates that SUZ is not financially healthy and even has some risk of bankruptcy.
SUZ's Altman-Z score of 1.22 is in line compared to the rest of the industry. SUZ outperforms 44.44% of its industry peers.
The Debt to FCF ratio of SUZ is 17.09, which is on the high side as it means it would take SUZ, 17.09 years of fcf income to pay off all of its debts.
SUZ has a Debt to FCF ratio (17.09) which is comparable to the rest of the industry.
A Debt/Equity ratio of 2.20 is on the high side and indicates that SUZ has dependencies on debt financing.
SUZ has a Debt to Equity ratio of 2.20. This is in the lower half of the industry: SUZ underperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.2
Debt/FCF 17.09
Altman-Z 1.22
ROIC/WACC1.07
WACC6.56%
SUZ Yearly LT Debt VS Equity VS FCFSUZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

SUZ has a Current Ratio of 3.16. This indicates that SUZ is financially healthy and has no problem in meeting its short term obligations.
SUZ's Current ratio of 3.16 is amongst the best of the industry. SUZ outperforms 100.00% of its industry peers.
SUZ has a Quick Ratio of 2.48. This indicates that SUZ is financially healthy and has no problem in meeting its short term obligations.
SUZ has a Quick ratio of 2.48. This is amongst the best in the industry. SUZ outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 2.48
SUZ Yearly Current Assets VS Current LiabilitesSUZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.85% over the past year.
The Revenue has grown by 19.24% in the past year. This is quite good.
SUZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.75% yearly.
EPS 1Y (TTM)62.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.52%
Revenue 1Y (TTM)19.24%
Revenue growth 3Y4.99%
Revenue growth 5Y12.75%
Sales Q2Q%-0.98%

3.2 Future

Based on estimates for the next years, SUZ will show a very strong growth in Earnings Per Share. The EPS will grow by 50.79% on average per year.
The Revenue is expected to grow by 11.50% on average over the next years. This is quite good.
EPS Next Y294.24%
EPS Next 2Y79.11%
EPS Next 3Y50.79%
EPS Next 5YN/A
Revenue Next Year8.71%
Revenue Next 2Y11.81%
Revenue Next 3Y11.54%
Revenue Next 5Y11.5%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SUZ Yearly Revenue VS EstimatesSUZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B
SUZ Yearly EPS VS EstimatesSUZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10

9

4. Valuation

4.1 Price/Earnings Ratio

SUZ is valuated reasonably with a Price/Earnings ratio of 8.86.
Based on the Price/Earnings ratio, SUZ is valued cheaper than 100.00% of the companies in the same industry.
SUZ's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
Based on the Price/Forward Earnings ratio of 7.13, the valuation of SUZ can be described as very cheap.
100.00% of the companies in the same industry are more expensive than SUZ, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.56, SUZ is valued rather cheaply.
Industry RankSector Rank
PE 8.86
Fwd PE 7.13
SUZ Price Earnings VS Forward Price EarningsSUZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SUZ is valued a bit cheaper than 77.78% of the companies in the same industry.
SUZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SUZ is cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.26
EV/EBITDA 5.45
SUZ Per share dataSUZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SUZ may justify a higher PE ratio.
SUZ's earnings are expected to grow with 50.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y79.11%
EPS Next 3Y50.79%

8

5. Dividend

5.1 Amount

SUZ has a Yearly Dividend Yield of 4.22%, which is a nice return.
Compared to an average industry Dividend Yield of 5.65, SUZ pays a better dividend. On top of this SUZ pays more dividend than 88.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, SUZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.22%

5.2 History

On average, the dividend of SUZ grows each year by 20.94%, which is quite nice.
SUZ has been paying a dividend for at least 10 years, so it has a reliable track record.
SUZ has decreased its dividend recently.
Dividend Growth(5Y)20.94%
Div Incr Years1
Div Non Decr Years1
SUZ Yearly Dividends per shareSUZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

SUZ pays out 32.13% of its income as dividend. This is a sustainable payout ratio.
SUZ's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP32.13%
EPS Next 2Y79.11%
EPS Next 3Y50.79%
SUZ Yearly Income VS Free CF VS DividendSUZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B
SUZ Dividend Payout.SUZ Dividend Payout, showing the Payout Ratio.SUZ Dividend Payout.PayoutRetained Earnings

SUZANO SA - SPON ADR

NYSE:SUZ (11/28/2025, 8:02:12 PM)

After market: 8.95 0 (0%)

8.95

-0.01 (-0.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners27.27%
Inst Owner Change-2.35%
Ins Owners15.51%
Ins Owner ChangeN/A
Market Cap11.06B
Revenue(TTM)47.40B
Net Income(TTM)7.83B
Analysts83.81
Price Target14.22 (58.88%)
Short Float %0.62%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield 4.22%
Yearly Dividend0.24
Dividend Growth(5Y)20.94%
DP32.13%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)104.78%
Min EPS beat(2)12.88%
Max EPS beat(2)196.69%
EPS beat(4)3
Avg EPS beat(4)-81.54%
Min EPS beat(4)-569.87%
Max EPS beat(4)196.69%
EPS beat(8)6
Avg EPS beat(8)-62.1%
EPS beat(12)9
Avg EPS beat(12)-31.22%
EPS beat(16)12
Avg EPS beat(16)-21.71%
Revenue beat(2)1
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-6.63%
Max Revenue beat(2)0.92%
Revenue beat(4)2
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-6.63%
Max Revenue beat(4)6.32%
Revenue beat(8)5
Avg Revenue beat(8)-0.03%
Revenue beat(12)7
Avg Revenue beat(12)-0.52%
Revenue beat(16)10
Avg Revenue beat(16)-0.12%
PT rev (1m)-1.21%
PT rev (3m)1.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)40.1%
EPS NY rev (1m)17.37%
EPS NY rev (3m)31.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.12%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-1.29%
Valuation
Industry RankSector Rank
PE 8.86
Fwd PE 7.13
P/S 1.15
P/FCF 10.26
P/OCF 2.92
P/B 1.37
P/tB 1.99
EV/EBITDA 5.45
EPS(TTM)1.01
EY11.28%
EPS(NY)1.25
Fwd EY14.02%
FCF(TTM)0.87
FCFY9.75%
OCF(TTM)3.07
OCFY34.27%
SpS7.77
BVpS6.54
TBVpS4.5
PEG (NY)0.03
PEG (5Y)N/A
Graham Number12.19
Profitability
Industry RankSector Rank
ROA 4.91%
ROE 18.14%
ROCE 8.99%
ROIC 7.05%
ROICexc 8.18%
ROICexgc 9.16%
OM 25.74%
PM (TTM) 15.26%
GM 37.73%
FCFM 11.22%
ROA(3y)7.7%
ROA(5y)3.96%
ROE(3y)26.78%
ROE(5y)-2.15%
ROIC(3y)9.38%
ROIC(5y)9.39%
ROICexc(3y)11.06%
ROICexc(5y)11.2%
ROICexgc(3y)12.82%
ROICexgc(5y)13.35%
ROCE(3y)11.96%
ROCE(5y)11.98%
ROICexgc growth 3Y-17.29%
ROICexgc growth 5Y26.8%
ROICexc growth 3Y-14.86%
ROICexc growth 5Y30.34%
OM growth 3Y-8.96%
OM growth 5Y26.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.3%
GM growth 5Y15.81%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 2.2
Debt/FCF 17.09
Debt/EBITDA 4
Cap/Depr 138.59%
Cap/Sales 28.23%
Interest Coverage 2.36
Cash Conversion 85.57%
Profit Quality 73.57%
Current Ratio 3.16
Quick Ratio 2.48
Altman-Z 1.22
F-Score7
WACC6.56%
ROIC/WACC1.07
Cap/Depr(3y)212.09%
Cap/Depr(5y)160.32%
Cap/Sales(3y)37.3%
Cap/Sales(5y)28.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.52%
EPS Next Y294.24%
EPS Next 2Y79.11%
EPS Next 3Y50.79%
EPS Next 5YN/A
Revenue 1Y (TTM)19.24%
Revenue growth 3Y4.99%
Revenue growth 5Y12.75%
Sales Q2Q%-0.98%
Revenue Next Year8.71%
Revenue Next 2Y11.81%
Revenue Next 3Y11.54%
Revenue Next 5Y11.5%
EBIT growth 1Y18.91%
EBIT growth 3Y-4.42%
EBIT growth 5Y42.3%
EBIT Next Year55.36%
EBIT Next 3Y26.69%
EBIT Next 5Y20.38%
FCF growth 1Y71.41%
FCF growth 3Y-30.27%
FCF growth 5Y9.93%
OCF growth 1Y-7.35%
OCF growth 3Y5.32%
OCF growth 5Y22.15%

SUZANO SA - SPON ADR / SUZ FAQ

What is the ChartMill fundamental rating of SUZANO SA - SPON ADR (SUZ) stock?

ChartMill assigns a fundamental rating of 7 / 10 to SUZ.


What is the valuation status of SUZANO SA - SPON ADR (SUZ) stock?

ChartMill assigns a valuation rating of 9 / 10 to SUZANO SA - SPON ADR (SUZ). This can be considered as Undervalued.


What is the profitability of SUZ stock?

SUZANO SA - SPON ADR (SUZ) has a profitability rating of 7 / 10.


How financially healthy is SUZANO SA - SPON ADR?

The financial health rating of SUZANO SA - SPON ADR (SUZ) is 5 / 10.


What is the earnings growth outlook for SUZANO SA - SPON ADR?

The Earnings per Share (EPS) of SUZANO SA - SPON ADR (SUZ) is expected to grow by 294.24% in the next year.